JP2003510285A5 - - Google Patents

Download PDF

Info

Publication number
JP2003510285A5
JP2003510285A5 JP2001526187A JP2001526187A JP2003510285A5 JP 2003510285 A5 JP2003510285 A5 JP 2003510285A5 JP 2001526187 A JP2001526187 A JP 2001526187A JP 2001526187 A JP2001526187 A JP 2001526187A JP 2003510285 A5 JP2003510285 A5 JP 2003510285A5
Authority
JP
Japan
Prior art keywords
echinacea
amount
composition
chinacea
polysaccharide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2001526187A
Other languages
English (en)
Other versions
JP4559683B2 (ja
JP2003510285A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/CA2000/000931 external-priority patent/WO2001022977A2/en
Publication of JP2003510285A publication Critical patent/JP2003510285A/ja
Publication of JP2003510285A5 publication Critical patent/JP2003510285A5/ja
Application granted granted Critical
Publication of JP4559683B2 publication Critical patent/JP4559683B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Claims (9)

  1. 約０．２ｍｇ／ｍｌから約５００ｍｇ／ｍｌのシコリイン酸、約０．０２ｍｇ／ｍｌから約５０ｍｇ／ｍｌのＥｃｈｉｎａｃｅａアルキルアミドおよび約１０ｍｇ／ｍｌから約８００ｍｇ／ｍｌのＥｃｈｉｎａｃｅａポリサッカライドを含む、Ｅｃｈｉｎａｃｅａ組成物。
  2. 前記シコリイン酸の量が、約０．３ｍｇ／ｍｌから約３０ｍｇ／ｍｌであり、前記Ｅｃｈｉｎａｃｅａアルキルアミドの量が、約０．０５ｍｇ／ｍｌから約５０ｍｇ／ｍｌであり、そして前記Ｅｃｈｉｎａｃｅａポリサッカライドの量が、約２０ｍｇ／ｍｌから約８００ｍｇ／ｍｌである、請求項１に記載のＥｃｈｉｎａｃｅａ組成物。
  3. 前記シコリイン酸の量が、約５．０ｍｇ／ｍｌから約３０ｍｇ／ｍｌであり、前記Ｅｃｈｉｎａｃｅａアルキルアミドの量が、約０．８ｍｇ／ｍｌから約５０ｍｇ／ｍｌであり、そして前記Ｅｃｈｉｎａｃｅａポリサッカライドの量が、約５０ｍｇ／ｍｌから約８００ｍｇ／ｍｌである、請求項２に記載のＥｃｈｉｎａｃｅａ組成物。
  4. 約０．０１ｍｇ／ｇから約５００ｍｇ／ｇのシコリイン酸、約０．００５ｍｇ／ｇから約１００ｍｇ／ｇのＥｃｈｉｎａｃｅａアルキルアミドおよび約５ｍｇ／ｇから約９００ｍｇ／ｇのＥｃｈｉｎａｃｅａポリサッカライドを含む、Ｅｃｈｉｎａｃｅａ組成物。
  5. 前記シコリイン酸の量が、約０．０５ｍｇ／ｇから約５００ｍｇ／ｇであり、前記Ｅｃｈｉｎａｃｅａアルキルアミドの量が、約０．１ｍｇ／ｇから約１００ｍｇ／ｇであり、そして前記Ｅｃｈｉｎａｃｅａポリサッカライドの量が、約１０ｍｇ／ｇから約９００ｍｇ／ｇである、請求項４に記載のＥｃｈｉｎａｃｅａ組成物。
  6. 前記シコリイン酸の量が、約１５ｍｇ／ｇから約５００ｍｇ／ｇであり、前記Ｅｃｈｉｎａｃｅａアルキルアミドの量が、約５ｍｇ／ｇから約１００ｍｇ／ｇであり、そして前記Ｅｃｈｉｎａｃｅａポリサッカライドの量が、約２００ｍｇ／ｇから約９００ｍｇ／ｇである、請求項４に記載のＥｃｈｉｎａｃｅａ組成物。
  7. 前記組成物が、固体またはゲルである、請求項４に記載のＥｃｈｉｎａｃｅａ組成物。
  8. Ｅｃｈｉｎａｃｅａ組成物を調製するための方法であって、該方法は、ある量のシコリイン酸、ある量のＥｃｈｉｎａｃｅａアルキルアミドおよびある量のＥｃｈｉｎａｃｅａポリサッカライドを混合して、約０．２ｍｇ／ｍｌから約５００ｍｇ／ｍｌのシコリイン酸、約０．０２ｍｇ／ｍｌから約５０ｍｇ／ｍｌのＥｃｈｉｎａｃｅａアルキルアミドおよび約１０ｍｇ／ｍｌから約８００ｍｇ／ｍｌのＥｃｈｉｎａｃｅａポリサッカライドを含むＥｃｈｉｎａｃｅａ組成物を生じる工程を包含する、方法。
  9. Ｅｃｈｉｎａｃｅａ組成物を調製するための方法であって、該方法は、ある量のシコリイン酸、ある量のＥｃｈｉｎａｃｅａアルキルアミドおよびある量のＥｃｈｉｎａｃｅａポリサッカライドを混合して、約０．０１ｍｇ／ｇから約５００ｍｇ／ｇのシコリイン酸、約０．００５ｍｇ／ｇから約１００ｍｇ／ｇのＥｃｈｉｎａｃｅａアルキルアミドおよび約５ｍｇ／ｇから約９００ｍｇ／ｇのＥｃｈｉｎａｃｅａポリサッカライドを含むＥｃｈｉｎａｃｅａ組成物を生じる工程を包含する、方法。
JP2001526187A 1999-09-30 2000-08-11 Ｅｃｈｉｎａｃｅａサプリメントおよびその製造方法 Expired - Fee Related JP4559683B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US15719499P 1999-09-30 1999-09-30
US60/157,194 1999-09-30
PCT/CA2000/000931 WO2001022977A2 (en) 1999-09-30 2000-08-11 Echinacea supplement and method of manufacture

Publications (3)

Publication Number Publication Date
JP2003510285A JP2003510285A (ja) 2003-03-18
JP2003510285A5 true JP2003510285A5 (ja) 2005-09-29
JP4559683B2 JP4559683B2 (ja) 2010-10-13

Family

ID=22562708

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2001526187A Expired - Fee Related JP4559683B2 (ja) 1999-09-30 2000-08-11 Ｅｃｈｉｎａｃｅａサプリメントおよびその製造方法

Country Status (14)

Country Link
US (2) US6511683B1 (ja)
EP (1) EP1220680B1 (ja)
JP (1) JP4559683B2 (ja)
CN (1) CN1240403C (ja)
AT (1) ATE388718T1 (ja)
AU (1) AU777453B2 (ja)
CA (1) CA2379581C (ja)
DE (1) DE60038308T2 (ja)
DK (1) DK1220680T3 (ja)
ES (1) ES2303512T3 (ja)
HK (1) HK1048943B (ja)
NZ (1) NZ517371A (ja)
PT (1) PT1220680E (ja)
WO (1) WO2001022977A2 (ja)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001085188A2 (en) * 2000-05-05 2001-11-15 Bioniche Life Sciences Inc. Use of echinacea as a hematinic agent
US6746697B2 (en) * 2000-12-15 2004-06-08 Phytos, Inc. Composition containing Heliopsis longipes root extract and oral carrier
EP1297751A1 (de) * 2001-10-01 2003-04-02 Bogar AG Oral zu verabreichende Zubereitung
NZ515182A (en) * 2001-10-31 2004-03-26 Brightwater Horticulture Ltd Extraction of biologically active compounds from plant material using acid and antioxidant
ITMI20021691A1 (it) * 2002-07-30 2004-01-30 Indena Spa Estratti di echinacea angustifolia
ITMI20021692A1 (it) * 2002-07-30 2002-10-29 Indena Spa Polisaccaride di echinacea angustifolia.
US20050002962A1 (en) * 2003-04-16 2005-01-06 David Pasco Immunostimulatory agents in botanicals
CN1297568C (zh) * 2003-08-08 2007-01-31 吉林威威药业股份有限公司 一种松果菊多糖、其制备方法及其在制备治疗抗病毒、抗菌及抗sars药物上的用途
US20050175721A1 (en) * 2004-02-06 2005-08-11 Brovelli Ernesto A. Method of augmenting the immune-modulatory activity of standardized Echinacea preparations
US8003136B2 (en) * 2004-03-03 2011-08-23 Randy Beavers Standardization of botanical products utilizing biological activity as a marker
AU2005259854C1 (en) * 2004-07-07 2011-06-02 Integria Healthcare (Australia) PTY LTD An Echinacea formulation
US20080124408A1 (en) * 2004-07-07 2008-05-29 Mediherb Holdings Ltd. Echinacea Formulation
US8597709B2 (en) * 2005-04-12 2013-12-03 Inovobiologic Inc. Dietary supplement and methods of use
US8062686B2 (en) * 2005-04-12 2011-11-22 InovoBiologics, Inc. Dietary supplement, and methods of use
US7491414B2 (en) * 2005-10-12 2009-02-17 Gaia Herbs, Inc. Anti-inflammatory substances extracted from Echinacea
US7829098B2 (en) * 2005-11-08 2010-11-09 Vita Green Health Products Co., Ltd Herbal powder extracts and methods of preparing and using the same
EP2737897A3 (en) * 2005-12-09 2014-10-01 Metaproteomics, LLC Anti-inflammatory botanical products for the treatment of metabolic syndrome and diabetes
CN101032541B (zh) * 2006-07-28 2011-05-11 成都地奥九泓制药厂 一种紫锥菊提取物及其制备方法和含量测定方法
CH699653B1 (de) * 2008-09-08 2010-05-14 Bioforce Ag Roggwil Tg Zubereitung zur Prävention und/oder Behandlung und/oder Verhinderung der Weiterverbreitung von Atemwegserkrankungen.
US8273385B1 (en) 2008-10-17 2012-09-25 Thres Flo, LLC Oral rinse composition and method
CN103906510A (zh) * 2011-10-11 2014-07-02 Elc管理公司 用于处理皮肤的方法和组合物
US8920855B1 (en) 2012-10-30 2014-12-30 Setem Hemth, Inc Methods of topically treating tinnitus and related disorders
KR102190710B1 (ko) * 2013-03-14 2020-12-14 마리 케이 인코포레이티드 화장품 조성물들
EP3335716A1 (en) * 2016-12-15 2018-06-20 Indena S.p.A. Process for the preparation of powder compositions
DE102017206827A1 (de) 2017-04-24 2018-10-25 Roman Gehre Gewinnung und Nutzung von Polyphenolen, insbesondere Cichoriensäure, aus Pflanzen der Gattung Posidonia
JP7488573B2 (ja) 2021-01-14 2024-05-22 株式会社山田養蜂場本社 マクロファージ活性剤

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0213099A3 (de) * 1985-08-23 1989-07-19 Cederroth Nordic Aktiebolag Mittel mit antiphlogistischer, immunstimulierender und zytoprotektiver Wirkung, ihre Herstellung und pharmazeutische Verwendungen
DE3744570A1 (de) * 1987-12-30 1989-07-13 Lohmann Rudolf Lomapharm Pharmazeutische zubereitungen mit immunstimulierender wirkung und verfahren zu ihrer herstellung
DE3744571A1 (de) * 1987-12-30 1989-07-13 Lohmann Rudolf Lomapharm Pharmazeutische zubereitungen zur stimulierung des immunsystems und verfahren zu ihrer herstellung
CH676931A5 (en) * 1988-08-02 1991-03-28 Spagyros S A Herbal medicaments prodn. - contg. essential antimicrobial oils and Echinacea tinctures, for treating infections, etc.
ATE123947T1 (de) * 1990-07-05 1995-07-15 Indena Spa Echinacea-extrakte, verfahren zur herstellung und zubereitungen, die sie enthalten.
US6355684B1 (en) * 1990-10-11 2002-03-12 Meryl J. Squires Antimicrobial treatment for herpes simplex virus and other infectious diseases
US5455033A (en) * 1993-05-21 1995-10-03 Degree/Silverman M.D. Inc. Medicinal composition for treatment of inflammation
FR2742987B1 (fr) * 1996-01-03 1998-04-03 Lvmh Rech Utilisation dans le domaine de la cosmetique et de la pharmacie, notamment de la dermatologie, d'un extrait d'eriobotrya japonica pour stimuler la synthese des glycosaminoglycanes
US6261565B1 (en) 1996-03-13 2001-07-17 Archer Daniels Midland Company Method of preparing and using isoflavones
CA2307614A1 (en) * 1997-10-23 1999-04-29 Elliot P. Friedman Pharmaceutical grade echinacea
US6217878B1 (en) * 1999-08-13 2001-04-17 Amway Corporation Method of preparing echinacea powder

Similar Documents

Publication Publication Date Title
JP2003510285A5 (ja)
JP2005516946A5 (ja)
JP2004535456A5 (ja)
JP2003506345A5 (ja)
JP2005520796A5 (ja)
JP2003503454A5 (ja)
DE60022230D1 (de) Verfahren zur herstllung von clarithromycin polymorphen und polymorph iv
TWI317736B (en) Methods for the production of redox proteins and heteromultimeric-protein-complexes, and related compositions related applications
DE69922880D1 (de) Enzymzusammensetzungen, die in vivo Oligosaccharide bilden können
JP2003508328A5 (ja)
HUP0202880A2 (hu) Nyújtott felszabadulású készítmények, eljárás előállításukra és alkalmazásuk
ATE326499T1 (de) Verfahren zur herstellung von funktionalierten polyalkyleniminen, diese enthaltende zusammenstellungen und ihre verwendungen
JP2005501968A5 (ja)
JO2249B1 (en) A compound of 6.3-dialkyl-6.5-dihydro-4-hydroxy-biran-2-one
HUP0303975A3 (en) Clathrate of azithromycin hydrate with 1,2-propyleneglycol, method for the manufacture thereof and pharmaceutical composition comprising same
CA2438622A1 (en) Compositions containing creatine and creatinine
ME00568A (en) Ciclesonide-containing aqueous pharmaceutical composition
JP2002114686A5 (ja)
JP2001294524A5 (ja)
EA200600173A1 (ru) Диспергируемая во рту фармацевтическая композиция антитромботического соединения
YU49435B (sh) Postupak za dobijanje kompaktiranih sipkavih sirovina za lakove
JP2000109457A5 (ja)
NO20023975D0 (no) Fremgangsmåte for fremstilling av metallkompleks av aminooligosakkaridderivat
JP2004517145A5 (ja)
DE50105577D1 (de) Ribavirin-granulat zur herstellung von filmtabletten